Table 4

Univariate and multivariable Cox analyses of sudden cardiac death and all-cause mortality risk across income quartiles

 SCD risk—Hazard ratioACM risk—Hazard ratio
Income groupUnivariateMultivariableaUnivariateMultivariablea
Q12.82 (2.62–3.0)2.17 (2.01–2.34)2.20 (2.15–2.26)1.72 (1.67–1.76)
Q21.96 (1.81–2.12)1.72 (1.59–1.86)1.66 (1.62–1.71)1.46 (1.43–1.50)
Q31.36 (1.25–1.47)1.32 (1.21–1.44)1.25 (1.22–1.29)1.23 (1.20–1.27)
Q41.0 (Ref.)
 SCD risk—Hazard ratioACM risk—Hazard ratio
Income groupUnivariateMultivariableaUnivariateMultivariablea
Q12.82 (2.62–3.0)2.17 (2.01–2.34)2.20 (2.15–2.26)1.72 (1.67–1.76)
Q21.96 (1.81–2.12)1.72 (1.59–1.86)1.66 (1.62–1.71)1.46 (1.43–1.50)
Q31.36 (1.25–1.47)1.32 (1.21–1.44)1.25 (1.22–1.29)1.23 (1.20–1.27)
Q41.0 (Ref.)

ACM, all-cause mortality; SCD, sudden cardiac death.

aThe multivariable Cox analysis was adjusted for age, sex, and comorbidities (heart failure, arrhythmia, ischaemic heart disease, cardiomyopathy, peripheral artery disease, diabetes mellitus, chronic obstructive pulmonary disease, cancer, cerebrovascular disease, epilepsy, liver disease, neurological disease, psychiatric disease, and sleep apnoea).

Table 4

Univariate and multivariable Cox analyses of sudden cardiac death and all-cause mortality risk across income quartiles

 SCD risk—Hazard ratioACM risk—Hazard ratio
Income groupUnivariateMultivariableaUnivariateMultivariablea
Q12.82 (2.62–3.0)2.17 (2.01–2.34)2.20 (2.15–2.26)1.72 (1.67–1.76)
Q21.96 (1.81–2.12)1.72 (1.59–1.86)1.66 (1.62–1.71)1.46 (1.43–1.50)
Q31.36 (1.25–1.47)1.32 (1.21–1.44)1.25 (1.22–1.29)1.23 (1.20–1.27)
Q41.0 (Ref.)
 SCD risk—Hazard ratioACM risk—Hazard ratio
Income groupUnivariateMultivariableaUnivariateMultivariablea
Q12.82 (2.62–3.0)2.17 (2.01–2.34)2.20 (2.15–2.26)1.72 (1.67–1.76)
Q21.96 (1.81–2.12)1.72 (1.59–1.86)1.66 (1.62–1.71)1.46 (1.43–1.50)
Q31.36 (1.25–1.47)1.32 (1.21–1.44)1.25 (1.22–1.29)1.23 (1.20–1.27)
Q41.0 (Ref.)

ACM, all-cause mortality; SCD, sudden cardiac death.

aThe multivariable Cox analysis was adjusted for age, sex, and comorbidities (heart failure, arrhythmia, ischaemic heart disease, cardiomyopathy, peripheral artery disease, diabetes mellitus, chronic obstructive pulmonary disease, cancer, cerebrovascular disease, epilepsy, liver disease, neurological disease, psychiatric disease, and sleep apnoea).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close